OTC Prilosec Overdose, Interaction Concerns Discounted By P&G
This article was originally published in The Tan Sheet
Executive Summary
Andrx' suggestion that OTC Prilosec would raise the danger of overdose because the heartburn medication takes several days to work "is without basis," Procter & Gamble asserts in a recent letter to FDA
You may also be interested in...
OTC Prilosec Risk/Benefit Ratio Relative To Current OTCs Questioned By Andrx
Uncertainties about the safety and efficacy of OTC Prilosec (omeprazole 20 mg) combined with "the relative effectiveness" of currently available nonprescription acid-reducers, should cause FDA to deny Procter & Gamble/AstraZeneca's switch NDA, Andrx says in a Nov. 20 citizen petition
Prilosec 1 Labeling Could Include Brand Names Of Contraindicated Drugs
Including brand names of Rx drugs that could interact with omeprazole on Prilosec 1 labeling was advocated by members of FDA's Nonprescription and Gastrointestinal Drugs Advisory Committees
Prilosec GERD Treatment Behavior Shown In Actual Use Studies - FDA
Consumers using AstraZeneca/Procter & Gamble's Prilosec 1 (omeprazole 10 mg) to prevent heartburn are likely to take the drug for longer than the 10-day limit set in proposed OTC labeling, according to agency reviewers.